Director Jill M. Quigley filed a Form 3 initial statement of beneficial ownership with the SEC on November 12, 2026, reporting her status as a newly reporting person at Filana Therapeutics, Inc. as of November 8, 2026.
Ryan Webster, VP of Fuel Fabrication at Oklo Inc., filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 12, 2026, reporting holdings as of the event date of November 4, 2026.
Paolo Tonucci, Chief Strategist and CEO of Capital Markets at Marex Group Ltd, filed a Form 4 on November 12, 2026, reporting the sale of 16,668 ordinary shares on November 9, 2026, pursuant to a Rule 10b5-1 plan.
Kathryn M. Horgan, Executive Vice President of State Street Corporation, filed a Form 4 on November 12, 2026, disclosing the sale of 6,437 shares of common stock on November 11, 2026, under a pre-established Rule 10b5-1 trading plan.
Mark A. Nelson, Vice Chairman of Chevron Corp, filed a Form 4 on November 12, 2026, reporting the exercise of two non-qualified stock options and the same-day sale of all resulting shares of common stock on November 10, 2026.
Director Kory Beth Sorenson filed an initial statement of beneficial ownership with the SEC on November 12, 2026, reporting no securities held in Marex Group Ltd as of the event date of November 2, 2026.
LifeVantage Corporation filed an 8-K on November 12, 2026, reporting the final voting results from its fiscal year 2027 annual meeting of stockholders held on November 5, 2026.
Atlanta Braves Holdings, Inc. EVP of Development Michael P. Plant filed a Form 4 on November 12, 2026, disclosing option exercises and open-market sales of Series C Common Stock conducted November 9 through November 11, 2026, pursuant to a Rule 10b5-1 sales plan.
STERIS plc filed an 8-K on November 12, 2026, disclosing that its subsidiary STERIS Irish FinCo Unlimited Company priced a $1.5 billion senior notes offering on November 9, 2026, with proceeds intended to help fund the pending acquisition of Xodus Medical, Inc.
Teva Pharmaceutical Industries Ltd. Chief Accounting Officer Amir Weiss filed a Form 4 on November 12, 2026, reporting the exercise of stock options and the sale of ordinary shares on November 9, 2026.